new nccn prostate cancer imaging indications using f18 pet / ct psma scan | pylarify | piflufolastat
Published 2 years ago • 1K plays • Length 7:38Download video MP4
Download video MP3
Similar videos
-
5:57
psma f18 pylarify piflufolastat radioligand theragnostics for prostate cancer
-
6:17
staging intermediate- and high-risk prostate cancer with 18f psma/pet/ct vs mri
-
4:09
psma pet-ct scan and treatments for patients with cn1 prostate cancer
-
1:08
what are the nccn guidelines?
-
1:35
psma-pet scanning and management of cn1 prostate cancer
-
1:01
genetic testing for prostate cancer | nccn guidelines
-
4:11
validation of psma-pet to the most used nomograms for pelvic lymph-node metastases prediction
-
6:29
comparing mri centers, mri vs. psma/pet for lymph nodes | answering youtube comments #71 | pcri
-
57:05
understanding uterine cancer treatment options
-
12:25
psma pet imaging for prostate cancer
-
0:35
ai-powered cartesion prime pet-ct
-
24:13
nccm 2024 | a brief overview on the latest cancer treatment in the 21st century | dr malwinder singh
-
2:02
angels den 2024 - no more needles: a non-invasive way to see kidney scarring
-
6:13
ep. 7: current treatment and imaging options for nmcrpc
-
2:03
precision imaging for breast cancer
-
1:57
meet dr. shirnett k. williamson | capital health cancer center
-
5:27
advances in cancer management pet:ct part 1
-
19:13
31 first line therapy: the role of biomarkers and nccn guidelines
-
0:32
nsclc workflows: tumor enrichment